Endocrinol Metab.  2010 Sep;25(3):166-170. 10.3803/EnM.2010.25.3.166.

Molecular Biology of Atherosclerosis

• Jeong IK

• KMID: 2169051
• DOI: http://doi.org/10.3803/EnM.2010.25.3.166

Abstract

No abstract available.

MeSH Terms

Atherosclerosis
Molecular Biology

Figure

• 

  Fig. 1 The schematic view of atherosclerosis: initiation events (A), lesion progression (B) and plaque rupture and thrombosis (C). (Adopted from Cell 104:503-516[2]).

• 

  Fig. 2 Probable mechanism of recruitment of bone marrow cells to ischemic or injured tissue. (Adopted from Am J Physiol Heart Circ Physiol 292:H1-H18, 2007[18]).

• 

  Fig. 3 Endothelial progenitor cell numbers inversely correlated with cardiovascular risk factors.

Reference

1. Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med. 1999. 340:115–126.

2. Glass CK, Witztum JL. Atherosclerosis. The road ahead. Cell. 2001. 104:503–516.

3. Napoli C, D'Armiento FP, Mancini FP, Postiglione A, Witztum JL, Palumbo G, Palinski W. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J Clin Invest. 1997. 100:2680–2690.

4. Williams KJ, Tabas I. Lipoprotein retention--and clues for atheroma regression. Arterioscler Thromb Vasc Biol. 2005. 25:1536–1540.

5. Son KP, Chae YJ, Lee TY, Jeong IK, Hur M, Jo GY, Lee Y, Lee SJ, Park CY, Oh KW, Hong EK, Kim HK, Yu JM, Kim DM, Lim SH, Choi MK, Yoo HJ, Park SW. The influence of metabolic syndrome on the intima-medial thickness and cardiovascular risk factors in type 2 diabetes. J Korean Diabetes Assoc. 2004. 28:1–15.

6. Shin HW, Jeong IK, Cho GY, Choi CY, Kim JY, Chae YJ, Cho MH, Lee BW, Lee SJ, Park CY, Hong EG, Kim HK, Kim DM, Yu JM, Ihm SH, Choi MK, Yoo HJ, Park SW. The changes in atherosclerotic markers and adiopocytokines after treatment with growth hormone for the patients with hypopituitarism and growth hormone deficiency. J Korean Endocr Soc. 2006. 21:515–525.

7. Cybulsky MI, Gimbrone MA Jr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science. 1991. 251:788–791.

8. Gosling J, Slaymaker S, Gu L, Tseng S, Zlot CH, Young SG, Rollins BJ, Charo IF. MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J Clin Invest. 1999. 103:773–778.

9. Qiao JH, Tripathi J, Mishra NK, Cai Y, Tripathi S, Wang XP, Imes S, Fishbein MC, Clinton SK, Libby P, Lusis AJ, Rajavashisth TB. Role of macrophage colony-stimulating factor in atherosclerosis: studies of osteopetrotic mice. Am J Pathol. 1997. 150:1687–1699.

10. Silverstein RL, Febbraio M. CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior. Sci Signal. 2009. 2:re3.

11. Rothblat GH, Phillips MC. High-density lipoprotein heterogeneity and function in reverse cholesterol transport. Curr Opin Lipidol. 2010. 21:229–238.

12. Gotsman I, Gupta R, Lichtman AH. The influence of the regulatory T lymphocytes on atherosclerosis. Arterioscler Thromb Vasc Biol. 2007. 27:2493–2495.

13. Pinderski LJ, Fischbein MP, Subbanagounder G, Fishbein MC, Kubo N, Cheroutre H, Curtiss LK, Berliner JA, Boisvert WA. Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient Mice by altering lymphocyte and macrophage phenotypes. Circ Res. 2002. 90:1064–1071.

14. Libby P, Okamoto Y, Rocha VZ, Folco E. Inflammation in atherosclerosis: transition from theory to practice. Circ J. 2010. 74:213–220.

15. Semenza GL. Vasculogenesis, angiogenesis, and arteriogenesis: mechanisms of blood vessel formation and remodeling. J Cell Biochem. 2007. 102:840–847.

16. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997. 275:964–967.

17. Hirschi KK, Ingram DA, Yoder MC. Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler Thromb Vasc Biol. 2008. 28:1584–1595.

18. Schatteman GC, Dunnwald M, Jiao C. Biology of bone marrow-derived endothelial cell precursors. Am J Physiol Heart Circ Physiol. 2007. 292:H1–H18.

19. Silvestre JS. Vascular progenitor cells and diabetes: role in postischemic neovascularisation. Diabetes Metab. 2008. 34:S33–S36.